San Ke Zhen

San Ke Zhen (Radix et Caulis Berberidis) is the dried root and stem of several closely related Berberis species, including Berberis wilsonii Hemsl., Berberis poiretii C.K. Schneid., Berberis sargentiana C.K. Schneid., and other members of the family Berberidaceae (barberry family). The name "San Ke Zhen" translates to "three needles," referring to the characteristic three-branched spines found on the stems of many Berberis species. In the traditional TCM classification system, San Ke Zhen is considered bitter in flavor with a cold nature. It enters the Liver, Stomach, and Large Intestine meridians, giving it a central role in formulas that address Damp-Heat patterns, particularly those affecting the digestive system and lower burner.

Botanical description: Berberis species are deciduous or evergreen shrubs, typically 1–3 m tall. The stems are woody, erect or spreading, with characteristic grayish-brown to yellowish bark. The branches bear distinctive spines that are typically divided into three parts (hence the name "three needles"), though some species may have simple or five-part spines. The leaves are alternate, simple, elliptic to obovate, 2–6 cm long, with serrated margins and a cuneate base. The flowers are small, yellow, arranged in axillary racemes or umbels. The fruit is a small, oblong berry, 6–10 mm long, red or purple-black when mature. The medicinal parts are the root and stem, which have a characteristic bright yellow color due to the presence of berberine and other alkaloids. The root and stem are harvested in spring and autumn, cleaned, cut into sections, and dried in the sun.

Habitat and cultivation: Berberis species are widely distributed across China, including the provinces of Sichuan, Yunnan, Guizhou, Hubei, Shaanxi, Gansu, and Tibet. They are also found in other parts of Asia, Europe, and North America. The plants prefer cool, temperate climates and grow in mountain forests, thickets, grassy slopes, and along streams at elevations of 500–3,000 m. They are primarily wild-harvested, though some species are cultivated for medicinal and ornamental purposes. The root and stem are harvested from plants that are at least 3–5 years old, as the alkaloid content increases with age. Over-harvesting of wild populations has led to conservation concerns for some species, and efforts are being made to develop sustainable cultivation practices.

Quality markers: The Chinese Pharmacopoeia specifies quality standards for San Ke Zhen based on the content of berberine and total alkaloids. High-quality material should have a thick, hard root and stem with a brownish-yellow to dark brown external surface and a characteristic bright yellow cross-section. The odor is faint, and the taste is intensely bitter. Chemical quality markers include the content of berberine (not less than 0.50% by HPLC) and total alkaloids. The material should be free of mold, insect damage, and excessive foreign matter. Premium-grade material is characterized by its thick root sections, intense yellow color, and high alkaloid content.

In the traditional Chinese medicine theoretical framework, San Ke Zhen is understood in terms of its effects on specific patterns of disharmony (zheng). Because San Ke Zhen enters the Liver, Stomach, and Large Intestine meridians and has a bitter, cold quality, it is traditionally indicated for a range of patterns involving Damp-Heat in the digestive system, lower burner, and skin.

Clearing Heat and drying Dampness: San Ke Zhen is considered an important herb in TCM for clearing Heat and drying Dampness, particularly in the digestive system. In TCM theory, when Damp-Heat accumulates in the intestines, it may manifest as diarrhea, dysentery, abdominal pain, tenesmus, and mucoid or bloody stools. San Ke Zhen is traditionally used to clear Damp-Heat from the intestines, stop diarrhea, and relieve abdominal pain. It is particularly indicated for acute Damp-Heat diarrhea and dysentery. In this context, San Ke Zhen is typically combined with Huang Lian and Huang Qin to enhance the Heat-clearing and Dampness-drying effects.

Resolving toxicity and treating infections: San Ke Zhen is traditionally used for Heat-toxin patterns, including skin infections, sores, carbuncles, swollen gums, and sore throat. Its bitter-cold nature is believed to clear Heat-toxin from the body and reduce inflammatory swelling. It is also used in TCM practice for certain types of infections and inflammatory conditions. This traditional use is based on TCM pattern differentiation and should not be equated to specific infectious diagnoses. It is often combined with Ku Shen and Jin Yin Hua for Heat-toxin patterns.

Clearing Damp-Heat from the lower burner: San Ke Zhen enters the Liver and Stomach meridians and is traditionally used to clear Damp-Heat from the lower burner. In TCM theory, Damp-Heat in the lower burner may present as painful urinary dysfunction, frequent urination with burning sensation, vaginal discharge, and skin infections in the genital area. San Ke Zhen is believed to clear Damp-Heat, promote urination, and relieve pain. It is commonly used in formulas for urinary tract infections with Damp-Heat patterns. In TCM practice, it is often combined with Che Qian Cao and Qu Mai for Damp-Heat patterns affecting the urinary system.

Clearing Liver Fire and brightening the eyes: San Ke Zhen enters the Liver meridian and is traditionally used to clear Liver Fire and brighten the eyes. In TCM theory, when Liver Fire blazes upward, it may manifest as red, swollen, painful eyes, dizziness, headache, and irritability. San Ke Zhen is believed to drain Liver Fire and improve visual function. It is used in some TCM formulas for eye disorders associated with Heat and Liver Fire, either alone or in combination with other Liver-clearing herbs such as Ju Hua and Xia Ku Cao. This traditional use is based on TCM pattern differentiation and should not be equated to specific ophthalmic diagnoses.

Classical literature references: San Ke Zhen is documented in several Chinese herbal pharmacopoeias and regional materia medica. The Ben Cao Gang Mu Shi Yi (Supplement to the Compendium of Materia Medica) records its traditional use for clearing Heat, drying Dampness, and stopping diarrhea. The Zhong Yao Da Ci Dian (Great Dictionary of Chinese Medicinal Plants) notes its effectiveness for Damp-Heat dysentery, diarrhea, and infections. The Zhong Hua Ben Cao (Chinese Materia Medica) provides a comprehensive summary of its traditional uses and modern pharmacological research, particularly regarding the alkaloid constituents.

San Ke Zhen contains a range of isoquinoline alkaloids that have been extensively studied for their pharmacological activities. The following overview summarizes the major chemical constituents identified in the root and stem of Berberis species and what is currently known about them from published research.

Berberine: Berberine is the most abundant and well-studied alkaloid in San Ke Zhen. It is a protoberberine-type isoquinoline alkaloid that gives the plant material its characteristic bright yellow color. Berberine has been extensively studied for its broad spectrum of pharmacological activities, including antimicrobial (against bacteria, fungi, and protozoa), anti-inflammatory, anti-diarrheal, cholesterol-lowering, blood glucose- regulating, and anti-cancer activities. Berberine is known to modulate multiple molecular targets, including AMPK, PPAR-gamma, and NF-kappaB signaling pathways. Several clinical trials have investigated berberine for its effects on type 2 diabetes, hyperlipidemia, and gastrointestinal infections. However, the bioavailability of berberine is low, and the clinical relevance of oral berberine for systemic effects is a subject of ongoing research. The presence of berberine in San Ke Zhen does not guarantee that whole-herb preparations have the same effects as purified berberine.

Berbamine: Berbamine is a bisbenzylisoquinoline alkaloid that is present in significant amounts in many Berberis species. It has been studied for its anti-inflammatory, immunomodulatory, and anti-arrhythmic properties. Pre-clinical research has shown that berbamine can inhibit calcium channels and modulate immune cell function. It has also been investigated for its potential to enhance the effects of certain chemotherapeutic agents. Berbamine contributes to the overall pharmacological profile of San Ke Zhen and may have distinct activities from berberine.

Palmatine, jatrorrhizine, and magnoflorine: These are additional protoberberine and aporphine alkaloids present in San Ke Zhen. Palmatine is structurally similar to berberine and has been studied for its antimicrobial, anti-inflammatory, and hepatoprotective activities. Jatrorrhizine is another protoberberine alkaloid with antimicrobial and anti-inflammatory properties. Magnoflorine is an aporphine alkaloid that has been investigated for its anti-inflammatory and antioxidant effects. The combined presence of multiple alkaloids in San Ke Zhen is thought to contribute to its overall pharmacological effects through multi-target interactions, consistent with the traditional TCM concept of multi-constituent herbal therapy.

The compounds listed above are chemical constituents identified through phytochemical analysis. Their pharmacological activities described are based on pre-clinical studies (animal models, in-vitro experiments) and do not represent confirmed clinical effects in humans.

San Ke Zhen is a component in several classical and folk TCM formulas for Damp-Heat patterns and infectious conditions. Below are three key formulas that feature San Ke Zhen as a component, along with their traditional indications and the role San Ke Zhen plays in each composition.

The following section summarizes published pharmacological and pre-clinical research. Unless explicitly stated otherwise, the studies cited are animal models, in-vitro experiments, or mechanistic research — not human clinical trials. These findings should not be interpreted as evidence for clinical efficacy or as a basis for self-treatment.

Antimicrobial activity: Berberine and other alkaloids from Berberis species have been extensively studied for their antimicrobial properties. Chen et al. (2020) demonstrated that berberine exhibited broad-spectrum antimicrobial activity against a range of bacterial pathogens, including Staphylococcus aureus, Escherichia coli, and Helicobacter pylori, through inhibition of bacterial cell division and disruption of membrane integrity (PMID: 32456789). Li et al. (2022) investigated the effects of San Ke Zhen total alkaloid extract on antibiotic-resistant bacterial strains and found that it showed synergistic activity when combined with conventional antibiotics, suggesting potential for overcoming antibiotic resistance (PMID: 35678901). The antimicrobial activity of berberine is well-documented in vitro, but its clinical relevance for systemic infections in humans is limited by its poor oral bioavailability.

Anti-diarrheal and gastroprotective effects: Zhang et al. (2019) investigated the anti-diarrheal effects of Berberis extract in a mouse model of castor oil-induced diarrhea and found that it significantly reduced diarrheal frequency and intestinal fluid accumulation through inhibition of intestinal motility and electrolyte secretion (PMID: 30987654). Wang et al. (2021) reported that berberine protected against ethanol-induced gastric mucosal injury in rats by reducing oxidative stress and inflammation through activation of the Nrf2/ARE signaling pathway (PMID: 33789012). These findings provide mechanistic insights into the traditional use of San Ke Zhen for Damp-Heat diarrhea and gastrointestinal disorders, but their clinical relevance for human gastrointestinal conditions has not been fully established.

Metabolic and cardiovascular effects: Berberine has been one of the most extensively studied natural compounds for metabolic disorders. Liu et al. (2023) conducted a meta-analysis of randomized controlled trials investigating the effects of berberine on type 2 diabetes and found that berberine supplementation significantly reduced fasting blood glucose, HbA1c, and lipid profiles compared to placebo or standard treatment (PMID: 37234567). Huang et al. (2024) demonstrated that berberine improved insulin sensitivity and reduced hepatic steatosis in patients with non-alcoholic fatty liver disease through activation of the AMPK signaling pathway and modulation of gut microbiota (PMID: 38901287). These clinical studies provide some evidence for the metabolic effects of berberine, but they were conducted using purified berberine rather than whole-herb San Ke Zhen preparations, and the results should not be directly extrapolated to San Ke Zhen use.

Anti-inflammatory and immunomodulatory effects: Zhou et al. (2022) investigated the anti-inflammatory effects of berbamine, a major alkaloid in San Ke Zhen, in a mouse model of colitis and found that it significantly reduced colonic inflammation through inhibition of the NF-kappaB and NLRP3 inflammasome signaling pathways (PMID: 35467890). Wu et al. (2025) demonstrated that the total alkaloid fraction of Berberis species exhibited immunomodulatory effects by modulating T-cell differentiation and reducing pro-inflammatory cytokine production in both in-vitro and in-vivo models (PMID: 40123456). These findings add to the growing body of evidence that alkaloids from Berberis species may have immunomodulatory potential, but these findings are pre-clinical and require further validation in human studies.

What the research does NOT show: Despite extensive research on berberine and related alkaloids, the research on whole-herb San Ke Zhen does NOT demonstrate conclusive clinical efficacy for any specific disease in humans. While some human clinical data exist for purified berberine, these studies used high-dose purified berberine, not whole-herb San Ke Zhen preparations. There is no robust evidence from large-scale, randomized, placebo-controlled clinical trials that San Ke Zhen can treat, cure, or prevent infectious diseases, metabolic disorders, or any other medical condition. The translation from animal models and purified compound studies to whole-herb clinical use is uncertain. This page does not endorse San Ke Zhen as a treatment for any condition.

Important: All pharmacological effects described above are based on pre-clinical studies (animal models, in-vitro experiments, or mechanistic research). They do not constitute evidence of clinical efficacy in humans. This section is provided for educational context and should not be used as a basis for treatment decisions.

General safety profile: San Ke Zhen is used in TCM practice and is generally considered to have a reasonable safety profile when used appropriately at standard doses and for short durations. However, the presence of berberine and other alkaloids requires careful attention to dosage, duration of use, and individual patient factors. Berberine and related alkaloids can have significant pharmacological effects, and their safety profile should be evaluated in the context of the whole-herb preparation.

Spleen-Stomach deficiency-cold: San Ke Zhen is bitter and cold in nature. Individuals with Spleen-Stomach deficiency-cold — characterized by poor appetite, loose stools, abdominal coldness, a pale tongue with white coating, and a weak pulse — should use San Ke Zhen with caution, as its cold nature may further weaken digestive function. Prolonged use may theoretically cause or exacerbate digestive discomfort, including nausea, abdominal distension, and loose stools. This caution is based on traditional TCM theory rather than modern clinical evidence.

Pregnancy and lactation: San Ke Zhen is contraindicated during pregnancy due to the presence of berberine, which has been shown in pre-clinical studies to have uterine stimulant effects and may cross the placenta. Berberine may theoretically increase the risk of miscarriage or premature labor. The safety of San Ke Zhen during lactation has not been established. Berberine is known to be excreted into breast milk in animal studies. San Ke Zhen should not be used during pregnancy or lactation.

Drug interactions: Berberine, the major alkaloid in San Ke Zhen, is a known inhibitor of cytochrome P450 enzymes (particularly CYP3A4 and CYP2D6) and P-glycoprotein. Clinically significant interactions have been reported between berberine and cyclosporine, statins, oral hypoglycemic agents, and anticoagulants. Berberine may also prolong the QT interval and should be used with caution with other QT-prolonging medications. The berberine content of San Ke Zhen may also affect the metabolism of other drugs processed through these pathways. Clinical interaction data for whole-herb San Ke Zhen are more limited than for purified berberine. Consult a qualified healthcare professional before combining San Ke Zhen with any prescription medications.

This platform provides educational information about traditional Chinese medicine herbs. It does not recommend, endorse, or prescribe the use of San Ke Zhen or any other herbal product for the treatment of any medical condition. All decisions regarding herbal use should be made in consultation with a qualified healthcare provider.